Status:

COMPLETED

Bovine Colostrum in Prevention of Sepsis and Retinopathy of Prematurity

Lead Sponsor:

Alexandria University

Conditions:

Preterm

Eligibility:

All Genders

1-3 years

Phase:

NA

Brief Summary

The aim of this study is to evaluate efficacy of bovine colostrum administration as a prophylaxis to decrease the incidence and the occurrence of retinopathy of prematurity in preterm neonates of gest...

Detailed Description

This study will include a randomized controlled trial carried out on preterm neonates who will fulfill the eligibility criteria delivered at Alexandria University Children's Hospital. Evaluation of th...

Eligibility Criteria

Inclusion

  • Preterm infants ≤ 32 weeks gestational age, weight ≤ 1500 gm. Start feeding in the first 72 hours of life

Exclusion

  • Exclusion criteria
  • Patients with any of the following will be excluded:
  • Obvious major congenital abnormalities.
  • Infants expected to be \>72 hours of age at the time of randomization.
  • Parental consent lacking/refusal

Key Trial Info

Start Date :

June 20 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2023

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT05438680

Start Date

June 20 2022

End Date

October 1 2023

Last Update

October 12 2023

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Alexandria university, Elshattbi hospital

Alexandria, Egypt, 0354

2

Marwa Mohamed Farag

Alexandria, Egypt, 0356